Note 6 - Intangibles

12 Months Ended

Oct. 03, 2015

Intangible Assets Disclosure [Text Block]

INTANGIBLES

	2015			2014
Patents and trademarks	$	2,203,673		$	2,153,717
Trade names		342,416			404,129
Non-competition agreements		150,048			177,090
Customer relationships		2,516,952			2,970,574
		5,213,089			5,705,510
Less accumulated amortization		(2,998,327	)		(2,845,250	)
Net intangibles	$	2,214,762		$	2,860,260

On December 9, 2011, we acquired, through a new wholly-owned subsidiary, substantially all of the assets of old M.C. Healthcare and acquired intangibles of approximately $3,980,000. At October 3, 2015 and September 27, 2014 we had intangibles associated with the asset acquisition of M.C. Healthcare of trade names, non-competition agreements and customer relationships (net of accumulated amortization of $1,115,246 and $1,005,865, respectively) of $1,894,170 and $2,545,928, respectively. Changes in the balances shown for trade names, non-competition agreements and customer relationships result solely from foreign currency fluctuations.

In addition, we had patents and trademarks (net of accumulated amortization) of $320,592 as of October 3, 2015 and $314,332 as of September 27, 2014. We reviewed the useful lives of individual patents and trademarks and determined that the useful lives did not require any material changes. The intangibles and the patents and trademarks are primarily associated with the medical segment.

Amortization expense for intangibles, patents and trademarks during fiscal years 2015, 2014, and 2013 was $326,775, $394,169, and $479,247, respectively. Estimated amortization expense for the next five fiscal years based on existing intangibles is as follows:

	Estimated
	Amortization
Fiscal Years	Expense
2016	$	289,257
2017		275,579
2018		271,977
2019		270,069
2020		269,171